Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant Therapy for H. pylori Eradication
NCT01922765Phase 4Unknown
- Sponsor
- The Catholic University of Korea
- Start
- Aug 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of amoxicillin, clarithromycin, metronidazole, rabeprazole in Helicobacter pylori infection, sponsored by The Catholic University of Korea. Status: unknown.
02
Drugs
amoxicillinclarithromycinmetronidazolerabeprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01922765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01922765.